Barr Proprietary R&D Unit May Be Incorporated As Separate Business
Executive Summary
Barr is seeking legal advice on whether its proprietary product development unit should remain a division of the company or be incorporated as a separate business.
You may also be interested in...
Ortho Low-Dose OC, EVRA Patch Will Counter Generics Of Tri-Cyclen In 2003
Ortho-McNeil's pending contraceptive line extensions will help the company expand the market for hormonal contraceptives, Johnson & Johnson Company Group Chairman Christine Poon said during a May 30 R&D meeting in La Jolla, Calif.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011